Guangzhou Sing May Hospital adheres to the philosophy of personalized and precise treatment, integrating a wide range of advanced oncology therapies. These include minimally invasive ablation techniques (cryoablation, microwave ablation, radiofrequency ablation, and NanoKnife), microvascular interventional therapies (such as conventional infusion, embolization, microsphere embolization, and specialized approaches like TAPIC—Transarterial Perfusion Immuno-Chemotherapy), immunotherapy, tumor-targeted immunomodulators, radiotherapy, chemotherapy, and other supportive treatments. The hospital provides comprehensive and standardized individualized treatment plans for patients who are not suitable for surgery or have limited physical tolerance, striving to offer internationally aligned, multidisciplinary, and integrated cancer care for every patient.

Currently, the Oncology Department at Sing May Hospital maintains extensive technical and clinical collaborations with top cancer centers both in China and abroad. It has successfully delivered personalized treatment plans to patients from across China, Southeast Asia, the Middle East, and other regions, achieving promising therapeutic outcomes. Backed by leading domestic and international medical technologies and a multidisciplinary team, the hospital is dedicated to safeguarding patients' health throughout their treatment journey.